GlassScriptPhysician profile
Meghan Keaton
NPI 1285899427
$5,794.94
in general payments reported to CMS, 2019-2025
28 companies · $572 in 2025
The $572 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,779 · 2020: $311 · 2021: $437 · 2022: $513 · 2023: $638 · 2024: $545 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,738 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,738.19 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $2,709.90 | 2019-2025 | Trikafta |
| Mylan Specialty L.P. | $557.71 | 2019-2024 | Tobi Podhaler |
| Abbvie INC. | $511.43 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $342.16 | 2019-2025 | Fasenra |
| Chiesi USA, INC. | $287.53 | 2019-2023 | Bronchitol, Pertzye |
| Regeneron Healthcare Solutions, INC. | $163.59 | 2019-2025 | Dupixent |
| Gilead Sciences, INC. | $160.81 | 2019-2021 | |
| Aimmune Therapeutics, INC. | $131.72 | 2024-2025 | Zenpep |
| Nestle Healthcare Nutrition INC. | $104.98 | 2021-2023 | |
| Digestive Care, INC. | $97.86 | 2023-2024 | Pertzye |
| Advanced Respiratory, INC | $77.79 | 2019-2021 | |
| Philips North America LLC | $74.83 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Vivus LLC | $63.47 | 2019-2020 | |
| Insmed, INC. | $62.54 | 2025 | Arikayce, Brinsupri |
| Phadia US INC. | $60.46 | 2019-2023 | Immunocap |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $56.33 | 2021-2025 | |
| Glaxosmithkline, LLC. | $38.90 | 2019-2025 | Nucala |
| Amgen INC. | $37.33 | 2021-2022 | |
| Genentech USA, INC. | $36.49 | 2021-2024 | Xolair |
| Viatris Specialty LLC | $35.58 | 2025 | Tobi Podhaler |
| Pari Respiratory Equipment, INC. | $30.28 | 2020 | |
| Allergan, INC. | $27.45 | 2019 | |
| Electromed, INC. | $26.11 | 2021-2023 | Smartvest |
| 3b Medical, INC. | $24.07 | 2025 | Luna |
| Baxter Healthcare | $21.26 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.82 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $17.86 | 2022 | |
| Breas Medical, INC. | $15.68 | 2024 | Vivo 45 Ls |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Keaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.